2022
DOI: 10.1016/j.jdin.2022.06.018
|View full text |Cite
|
Sign up to set email alerts
|

Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…Compared to the general population, patients with moderate-to-severe psoriasis are at a high risk of depression and anxiety. The burden of mental health disorders among patients with moderate-to-severe psoriasis is substantial (Milan et al, 2022).…”
Section: Anxiety and Depression In Psoriasis Patientsmentioning
confidence: 99%
“…Compared to the general population, patients with moderate-to-severe psoriasis are at a high risk of depression and anxiety. The burden of mental health disorders among patients with moderate-to-severe psoriasis is substantial (Milan et al, 2022).…”
Section: Anxiety and Depression In Psoriasis Patientsmentioning
confidence: 99%